Lars Jørgen Østergaard

Vaccination til forebyggelse af meningokoksygdom

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Nanna Himmelstrup, Amager og Hvidovre hospital, København
  • ,
  • Cecilie Helkjær Engen, Amager og Hvidovre hospital, København
  • ,
  • Lars Østergaard
  • Thomas Lars Benfield, Amager og Hvidovre hospital, København, University of Copenhagen

Neisseria meningiditis is a cause of sepsis and meningitis. Based on the capsule, six groups are recognised to cause invasive disease: A, B, C, W135, X and Y. In Denmark, five vaccines are marketed to protect against five of the six groups. One conjugated glycoprotein vaccine against serogroup C alone: MenC, two conjugated vaccines against ACWY: ACWY-TT/ACWY-CRM, and two protein-based vaccines against serogroup B: 4CMenB and MenB-fHbp. Overall, the efficacy is good, but the persistence of immunity is decreasing over time, why a booster is recommended for long-term protection.

Translated title of the contributionVaccination for meningococcal disease
Original languageDanish
Article numberV09180611
JournalUgeskrift for Laeger
Publication statusPublished - Jan 2019

See relations at Aarhus University Citationformats

ID: 176168880